Dascena, Inc.

Dascena, Inc. develops advanced diagnostic tools that utilize machine learning and artificial intelligence to enhance clinical decision-making in healthcare, focusing on improving patient outcomes through predictive analytics. Founded in 2014 in Houston, US, Dascena, Inc. specializes in healthcare analytics, particularly in critical care settings.

The company has completed a total of 5 deals, with their most recent deal occurring on August 3, 2022. Dascena received a GRANT of USD 0. 230 mn from the National Science Foundation, contributing to a total amount raised of USD 20. 850 mn.

The founder, Ritankar Das, serves as the CEO and has a background in healthcare technology. Dascena specializes in developing advanced diagnostic tools that leverage machine learning and artificial intelligence to improve clinical decision-making in healthcare. The company’s core offerings include predictive analytics platforms aimed at assisting healthcare professionals in identifying and managing various conditions, particularly within critical care. Their products are designed to enhance patient outcomes by providing timely insights based on patient data.

Dascena serves a diverse clientele, including hospitals, healthcare systems, and diagnostic laboratories primarily in the United States, with plans for broader market exploration as AI-driven healthcare solutions gain traction globally. Dascena operates on a business-to-business (B2B) model, establishing partnerships with healthcare providers and institutions. The company generates revenue through subscription agreements for access to its predictive analytics platforms, which may feature tiered pricing based on implementation scale and user count. Clients incorporate Dascena’s technology within their existing healthcare systems to enhance patient care and optimize operational efficiencies.

While the specifics of pricing plans are not disclosed, the firm’s flagship products are tailored to address the needs of contemporary healthcare environments. Dascena plans to expand its product offerings by designing new predictive analytics tools in the coming year, aimed at enhancing diagnostic capabilities in diverse healthcare settings. The company is also targeting expansion into international markets, with a focus on regions in Europe and Asia by 2025. The recent funding from the National Science Foundation will support these initiatives, enabling Dascena to further develop and market its innovative healthcare solutions.